Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 1
---
 the instructions on the proxy card regarding each of these voting options. Your continued support of and interest in Phathom Pharmaceuticals, Inc. are sincerely appreciated. Sincerely,

| Steven Basta                                    |
| President, Chief Executive Officer and Director |

<div align='center'>i</div>

100 Campus Drive, Suite 102 Florham Park, NJ 07932 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS AND PROXY STATEMENT

| DATE & TIME:       
 PLACE:             | June 3, 2025 at 11:30 a.m., Eastern Time.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 This year’s Annual Meeting will be a virtual meeting, which will be conducted only via live webcast. Stockholders will only be able to participate in the Annual Meeting online, vote shares electronically and submit questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/PHAT2025. Instructions on how to attend the Annual Meeting online and vote shares are described in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                  |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ITEMS OF BUSINESS: | (1) To elect two directors to serve as Class III directors for a three-year term to expire at the 2028 annual meeting of stockholders; (2) To ratify the appointment of Ernst & Young LLP by the Audit Committee of the Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025; (3) To approve the compensation of the named executive officers on a non-binding advisory basis (“say-on-pay”); (4) To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers (“say-on-frequency”); and (5) To transact such other business as may properly come before the meeting or any adjournment thereof. |
| RECORD DATE:       | You are entitled to vote at the annual meeting or any adjournment of that meeting only if you were a stockholder at the close of business on April 7, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| VOTING BY PROXY:   | Please submit a proxy as soon as possible so that your shares can be voted at the meeting in accordance with your instructions. You may submit your proxy (1) over the Internet, (2) by telephone, or (3) by mail. For specific instructions, please refer to the information in the proxy statement and the instructions